Apimeds Pharmaceuticals US, Inc. Common Stock (NY:APUS)

3.080 UNCHANGED

Streaming Delayed Price Updated: 8:00 PM EST, Nov 18, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	3.080
Bid (Size)	2.960 (100)
Ask (Size)	3.290 (100)
Prev. Close	3.080
Today's Range	3.080 - 3.080
52wk Range	1.430 - 4.031
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 18, 2025

Via Benzinga

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

November 10, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Performance

YTD	+77.0%	+77.0%
1 Month	+69.2%	+69.2%
3 Month	+62.1%	+62.1%
6 Month	+77.0%	+77.0%
1 Year	+77.0%	+77.0%

More News

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon’s Lundquist College of Business

October 14, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 16, 2025

Via Benzinga

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

September 15, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

September 11, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 05, 2025

Via Benzinga

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

August 25, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 21, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-08-21: top gainers and losers in today's session. ↗

August 21, 2025

Via Chartmill

Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division

July 15, 2025

From Apimeds Pharmaceuticals US, Inc.

Via Business Wire

Frequently Asked Questions

Is Apimeds Pharmaceuticals US, Inc. Common Stock publicly traded?

Yes, Apimeds Pharmaceuticals US, Inc. Common Stock is publicly traded.

What exchange does Apimeds Pharmaceuticals US, Inc. Common Stock trade on?

Apimeds Pharmaceuticals US, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock?

The ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock is APUS on the New York Stock Exchange

What is the current price of Apimeds Pharmaceuticals US, Inc. Common Stock?

The current price of Apimeds Pharmaceuticals US, Inc. Common Stock is 3.080

When was Apimeds Pharmaceuticals US, Inc. Common Stock last traded?

The last trade of Apimeds Pharmaceuticals US, Inc. Common Stock was at 11/18/25 08:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.